Regional Hematology and Oncology PA — Newark, Delaware

Regional Hematology and Oncology PA is a clinical research site located in Newark, Delaware, United States 19713.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Regional Hematology and Oncology PA has participated in 46 clinical trials with 11 currently active.

Therapeutic areas: Lymphedema, Stage IA Cervical Cancer, Stage IA Uterine Corpus Cancer.

Sponsors: Gynecologic Oncology Group, ECOG-ACRIN Cancer Research Group, University of Rochester NCORP Research Base.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Regional Hematology and Oncology PA?

Regional Hematology and Oncology PA has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Regional Hematology and Oncology PA conducted?

Regional Hematology and Oncology PA has 46 clinical trials on record, with 11 currently active. Their work covers Lymphedema, Stage IA Cervical Cancer, Stage IA Uterine Corpus Cancer.

Is Regional Hematology and Oncology PA accredited by Crixeo Health?

Regional Hematology and Oncology PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Regional Hematology and Oncology PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.